Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK10 | P53779 | 8/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | GFER | P55789 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | FDPS | P14324 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 3/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.45 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.45 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | IGF1R | P08069 | 1/20 | 0.44 |
| ▸ | LTK | P29376 | 1/20 | 0.44 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.44 |
| ▸ | CLK2 | P49760 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6923905 | 0.89 | MAPK10 (0.57) | MAPK10MEN1KMT2AGFERMAPK8 | |
| SCHEMBL13151491 | 0.83 | MAPK10 (0.62) | MAPK10NPC1RAB9AFDPSEGFR | |
| SCHEMBL29391624 | 0.79 | KMT2A (0.76) | MAPK10MEN1KMT2AGFERNPC1 | |
| SCHEMBL221242 | 0.79 | KMT2A (0.76) | MAPK10MEN1KMT2AGFERNPC1 | |
| SCHEMBL11133606 | 0.77 | KMT2A (0.73) | MAPK10MEN1KMT2AGFERNPC1 | |
| SCHEMBL4243882 | 0.77 | KMT2A (0.73) | MAPK10MEN1KMT2AGFERNPC1 | |
| SCHEMBL30947359 | 0.77 | KMT2A (0.73) | MAPK10MEN1KMT2AGFERNPC1 | |
| SCHEMBL6175584 | 0.77 | KMT2A (0.73) | MAPK10MEN1KMT2AGFERNPC1 | |
| SCHEMBL6574416 | 0.77 | KMT2A (0.73) | MAPK10MEN1KMT2AGFERNPC1 | |
| Bromide SCHEMBL28368455 | 0.77 | KMT2A (0.73) | MAPK10MEN1KMT2AGFERNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10876047-B2 | Phosphorescent emitting compositions | R DISPLAY & LIGHTING LLC (US) | 2020-12-29 | — | — | US | disclosed |
| EP-2391605-B1 | SCRIPTAID ISOSTERES AND THEIR USE IN THERAPY | KARUS THERAPEUTICS LTD (GB) | 2017-11-08 | — | — | EP | disclosed |
| US-20170174985-A1 | PHOSPHORESCENT EMITTING COMPOSITIONS | R-Display & Lighting LLC (US) | 2017-06-22 | — | — | US | disclosed |
| US-9340503-B2 | Scriptaid isosteres and their use in therapy | KARUS THERAPEUTICS, LIMITED (GB) | 2016-05-17 | — | — | US | disclosed |
| US-9340503-B2 | Scriptaid isosteres and their use in therapy | KARUS THERAPEUTICS, LIMITED (GB) | 2016-05-17 | — | — | US | disclosed |
| US-20140235671-A1 | SCRIPTAID ISOSTERES AND THEIR USE IN THERAPY | KARUS THERAPEUTICS LIMITED (GB) | 2014-08-21 | — | — | US | disclosed |
| US-20140235671-A1 | SCRIPTAID ISOSTERES AND THEIR USE IN THERAPY | KARUS THERAPEUTICS LIMITED (GB) | 2014-08-21 | — | — | US | disclosed |
| US-8748458-B2 | Scriptaid isosteres and their use in therapy | KARUS THERAPEUTICS LIMITED (GB) | 2014-06-10 | — | — | US | disclosed |
| US-8748458-B2 | Scriptaid isosteres and their use in therapy | KARUS THERAPEUTICS LIMITED (GB) | 2014-06-10 | — | — | US | disclosed |
| US-20110305729-A1 | Scriptaid Isosteres and Their Use in Therapy | KARUS THERAPEUTICS LIMITED (GB) | 2011-12-15 | — | — | US | disclosed |
| US-20110305729-A1 | Scriptaid Isosteres and Their Use in Therapy | KARUS THERAPEUTICS LIMITED (GB) | 2011-12-15 | — | — | US | disclosed |
| WO-2010086646-A1 | SCRIPTAID ISOSTERES AND THEIR USE IN THERAPY | KARUS THERAPEUTICS LIMITED (GB) | 2010-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235671-A1 | SCRIPTAID ISOSTERES AND THEIR USE IN THERAPY | QARS1, C1QBP, QTRT1 | MAPK10 3799/4885MEN1 3591/4885KMT2A 1846/4885 |
| US-20110305729-A1 | Scriptaid Isosteres and Their Use in Therapy | QARS1, C1QBP, C1S | MAPK10 3699/4885MEN1 3542/4885KMT2A 1856/4885 |
| US-20170174985-A1 | PHOSPHORESCENT EMITTING COMPOSITIONS | OCIAD2, OCIAD1, ORC3 | MAPK10 1921/4885MEN1 2088/4885KMT2A 4169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.